S-RMab? PAX5 Recombinant Rabbit mAb (SDT-R202)

產(chǎn)品型號：S0B2226

更新時(shí)間：2025-10-09

廠商性質(zhì)：生產(chǎn)廠家

訪問量：79

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對抗體病理/IHC抗體

查看全部產(chǎn)品

癌癥治療新紀(jì)元：ADC藥物如何以“精準(zhǔn)制導(dǎo)+超級彈頭“改寫抗癌規(guī)則？

成纖維細(xì)胞生長因子21：代謝調(diào)控的新星與治療前沿

GFAP Mouse mAb的應(yīng)用領(lǐng)域有哪些？

產(chǎn)品介紹

The transcription factor Pax5 is essential for commitment of lymphoid progenitors to the B lymphocyte lineage. Pax5 fulfils a dual role by repressing B lineage 'inappropriate' genes and simultaneously activating B lineage–specific genes. This transcriptional reprogramming restricts the broad signaling capacity of uncommitted progenitors to the B cell pathway, regulates cell adhesion and migration, induces VH-DJH recombination, facilitates （pre-）B cell receptor signaling and promotes development to the mature B cell stage. Conditional Pax5 inactivation in early and late B lymphocytes revealed an essential role for Pax5 in controlling the identity and function of B cells throughout B lymphopoiesis. PAX5 has also been implicated in human B cell malignancies, as it is deregulated by chromosomal translocations in a subset of acute lymphoblastic leukemias and non-Hodgkin lymphomas.

上一個(gè)：S0B2225Mesothelin Recombinant Rabbit mAb (SDT-347-15)